Tag: Charmaine Chan

In our third Q&A segment on COVID-19, Cambiar Senior Analyst Charmaine Chan provides insights into the mutated version of the virus and the efficacy of vaccines.

Cambiar Senior Analyst Charmaine Chan provides her second Q&A segment on COVID-19.  She details the latest on possible vaccines, the next steps for the U.S. on the road to recovery, and the likeliness of a second wave of coronavirus.

Cambiar Senior Analyst Charmaine Chan provides an assessment of the virus and outlook for a potential treatment.

Cambiar Senior Analyst Charmaine Chan discusses potential impacts on the healthcare sector as we move into the election season.